HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
81.18
-2.34 (-2.80%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HealthEquity Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$115.00
Upside
+41.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold → Buy Upgrades $85 → $105 | Hold → Buy | Upgrades | $85 → $105 | +29.34% | Apr 9, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $120 → $128 | Strong Buy | Maintains | $120 → $128 | +57.67% | Mar 19, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $125 → $110 | Buy | Maintains | $125 → $110 | +35.50% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $129 → $123 | Buy | Maintains | $129 → $123 | +51.52% | Mar 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $100 | Buy | Maintains | $110 → $100 | +23.18% | Mar 18, 2026 |
| Barclays | Barclays | Buy Maintains $118 → $110 | Buy | Maintains | $118 → $110 | +35.50% | Feb 18, 2026 |
| BTIG | BTIG | Strong Buy Maintains $130 → $110 | Strong Buy | Maintains | $130 → $110 | +35.50% | Feb 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $89 | Hold → Strong Sell | Downgrades | $89 | +9.63% | Jan 9, 2026 |
| Keybanc | Keybanc | Buy Maintains $120 → $125 | Buy | Maintains | $120 → $125 | +53.98% | Jan 8, 2026 |
| Barclays | Barclays | Buy Initiates $118 | Buy | Initiates | $118 | +45.36% | Dec 9, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $125 | Buy | Maintains | $125 | +53.98% | Dec 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $126 → $129 | Buy | Maintains | $126 → $129 | +58.91% | Dec 4, 2025 |
| Citizens | Citizens | Buy Maintains $117 → $122 | Buy | Maintains | $117 → $122 | +50.28% | Dec 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $130 | Strong Buy | Reiterates | $130 | +60.14% | Dec 4, 2025 |
| BMO Capital | BMO Capital | Hold Initiates $100 | Hold | Initiates | $100 | +23.18% | Nov 13, 2025 |
| Keybanc | Keybanc | Buy Maintains $125 → $120 | Buy | Maintains | $125 → $120 | +47.82% | Oct 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.